Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIOCIGUAT vs RIPRETINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIOCIGUAT vs RIPRETINIB: Safety Overview

Metric RIOCIGUAT RIPRETINIB
Total FAERS Reports 18,268 4,432
Deaths Reported 5,380 465
Death Rate 29.5% 10.5%
Hospitalizations 7,951 948
Average Patient Age 63.9 yrs 66.8 yrs
% Female Patients 70.6% 45.3%
FDA Approval Date Oct 8, 2013 May 15, 2020
Manufacturer Bayer HealthCare Pharmaceuticals Inc. Deciphera Pharmaceuticals, LLC
Route ORAL ORAL
Marketing Status Prescription Prescription